A phase 1/2 study of selinexor in combination with standard of care therapy for newly diagnosed or recurrent glioblastoma.
Other Scholarly Work
Odia, Yazmin, Goldlust, Samuel Aaron, Mehta, Minesh P et al. (2021). A phase 1/2 study of selinexor in combination with standard of care therapy for newly diagnosed or recurrent glioblastoma.
. JOURNAL OF CLINICAL ONCOLOGY, 39(15), 10.1200/JCO.2021.39.15_suppl.TPS2071
Odia, Yazmin, Goldlust, Samuel Aaron, Mehta, Minesh P et al. (2021). A phase 1/2 study of selinexor in combination with standard of care therapy for newly diagnosed or recurrent glioblastoma.
. JOURNAL OF CLINICAL ONCOLOGY, 39(15), 10.1200/JCO.2021.39.15_suppl.TPS2071